Ligelizumab

From Wikipedia, the free encyclopedia
Ligelizumab ?
Monoclonal antibody
Type Whole antibody
Source Humanized
Target IGHE
Clinical data
Legal status ?
Identifiers
CAS number 1322627-61-1
ATC code None
Chemical data
Formula ?

Ligelizumab (INN) is a humanized monoclonal antibody that binds to IGHE. It acts as an immunomodulator.[1]

References

  1. World Health Organization (2012). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 107" (PDF). WHO Drug Information 26 (2). 



This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.